查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566966

生物程序袋市場：按類型、工作流程和最終用戶分類：2024-2033 年全球機會分析和產業預測

Bioprocess Bags Market By Type , By Workflow By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 260 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年生物程序袋市場規模為33億美元，預計2033年將達149億美元，2024年至2033年複合年成長率為16.4%。

生物程序袋是由高等級聚合物製成的一次性高性能袋子，可用於生物製藥液體的儲存、物料輸送和運輸，包括細胞培養基、介質、緩衝液和其他關鍵材料。過程應用，例如這些袋子旨在保持無菌並降低交叉污染的風險。由於對可提高效率和更大操作靈活性的一次性技術的需求不斷增加，其用途正在迅速擴大。

全球生物加工袋市場的成長主要是由於對疫苗、單株抗體和細胞療法等生物製藥的需求激增，以及由於成本效益和風險降低而擴大採用一次性技術的污染。研究表明，與傳統不銹鋼系統相比，在細胞培養過程中使用生物程序袋可以將交叉污染的風險降低 90% 以上，因為其一次性使用且無需複雜的清洗程序。此外，與傳統的不銹鋼系統相比，生物程序袋可以降低資本和營運成本，例如減少清洗和驗證要求，這是全球市場的關鍵驅動力。此外，與這些袋子相關的多種優勢促進了市場的成長。例如，袋子可以在生物製造過程中輕鬆快速地實現可擴展性，這對於滿足對生技藥品和個人化藥物日益成長的需求至關重要。此外，在大流行等全球健康挑戰的刺激下，對疫苗和其他生物製藥的需求增加了對生物程序袋進行高效生產和分銷的依賴。由於需要減少對環境的影響並提高生物製造過程的整體永續性，該行業正在轉向在生物程序袋中使用永續和環保的材料，預計這將大大促進市場成長。然而，一次性生物加工袋產生大量塑膠廢棄物，加上對其環境影響的日益擔憂以及對永續處理方法的壓力越來越大，正在阻礙市場的成長。此外，與生物處理袋中使用的聚合材料中的可浸出物和萃取物污染產品相關的潛在風險阻礙了生物處理袋的使用。相反，生物程序袋材料和設計的持續進步，例如改進的阻隔性能和對廣泛生物程序應用的適用性，預計將為預測期內的市場成長提供有利的機會。此外，製造商也致力於提高生物製程袋的無菌性並維持產品完整性，這滿足了高價值生技藥品無污染生產的迫切需求。此類新興市場的開拓預計將為市場成長開闢新的途徑。

全球生物程序袋產業按類型、工作流程、最終用戶和地區細分。按類型分類，市場分為 2D 生物程序袋、3D 生物程序袋等。依工作流程可分為上游工程、下游流程、流程開發。依最終用戶分為製藥/生物製藥公司、CMO/CRO、學術/研究機構。從區域來看，分析涵蓋北美、歐洲、亞太地區和拉丁美洲/中東/非洲。

主要發現

按類型分類，預計 2D 生物程序袋細分市場將在 2024 年至 2033 年期間佔據市場主導地位。

根據工作流程，上游工程部分預計將在預測期內呈現最高成長。

從最終用戶來看，製藥和生物技術公司預計將在未來幾年成為主導領域。

按地區分類，就 2023 年以收益為準，北美佔據最大市場佔有率，預計在預測期內也將主導市場。

可以使用此報告進行客製化（需要額外費用和時間表）

  • 根據客戶興趣加入公司簡介
  • 擴大公司簡介列表

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 關鍵投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章生物程序袋市場：依類型

  • 市場概況
  • 2D生物程序袋
  • 3D生物程序袋
  • 其他

第5章生物程序袋市場：依工作流程

  • 市場概況
  • 上游工程
  • 下游工藝
  • 製程開發

第6章生物程序袋市場：依最終用戶分類

  • 市場概況
  • 製藥和生物製藥公司
  • 首席行銷長和首席研究官
  • 學術/研究機構

第7章生物程序袋市場：依地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國生物程序袋市場
    • 加拿大生物程序袋市場
    • 墨西哥生物程序袋市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 法國生物程序袋市場
    • 德國生物程序袋市場
    • 義大利生物程序袋市場
    • 西班牙生物程序袋市場
    • 英國生物程序袋市場
    • 其他歐洲生物程序袋市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 中國生物程序袋市場
    • 日本生物程序袋市場
    • 印度生物程序袋市場
    • 韓國生物程序袋市場
    • 澳洲生物程序袋市場
    • 其他亞太地區生物程序袋市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西生物程序袋市場
    • 南非生物程序袋市場
    • 沙烏地阿拉伯生物程序袋市場
    • 其他拉丁美洲/中東/非洲生物程序袋市場

第8章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第9章 公司簡介

  • Thermo Fisher Scientific Inc.
  • Sartorius AG
  • Merck KGaA
  • Danaher Corporation
  • Saint-Gobain Performance Plastics.
  • Lonza Group AG
  • Eppendorf AG
  • Meissner Filtration Products, Inc.
  • PBS Biotech, Inc.
  • GE Healthcare
簡介目錄
Product Code: A324380

The bioprocess bags market was valued at $3.3 billion in 2023, and is projected to reach $14.9 billion by 2033, growing at a CAGR of 16.4% from 2024 to 2033.

Bioprocess bag is a single-use, high-performance bag that is made from high-grade polymers, making it compatible for a wide range of bioprocessing applications such as storage, handling, and transportation of biopharmaceutical fluids, including cell cultures, media, buffers, and other critical materials. These bags are designed to maintain the sterility and reduce the risk of cross-contamination. Their use is rapidly expanding due to the growing demand for single-use technologies, which offer increased efficiency and superior operational flexibility.

The growth of the global bioprocess bags market is majorly driven by surge in demand for biopharmaceuticals, such as vaccines, monoclonal antibodies, and cell therapies as well as increase in adoption of single-use technologies due to their cost-effectiveness and reduced risk of contamination. Studies have shown that the use of bioprocess bags in cell culture processes can reduce the risk of cross-contamination by over 90% compared to traditional stainless steel systems, due to their single-use nature and elimination of complex cleaning procedures. Furthermore, bioprocess bags offer lower capital and operational costs compared to traditional stainless steel systems, including reduced cleaning and validation requirements, which acts as a key driving force of the global market. Moreover, multiple benefits associated with these bags augment the market growth; for instance, they allow for easy and quick scalability in biomanufacturing processes, which is crucial in meeting the growing demand for biologics and personalized medicines. In addition, the demand for vaccines and other biopharmaceutical products, spurred by global health challenges like pandemics, has increased the reliance on bioprocess bags for efficient production and distribution. The industry is shifting toward the use of sustainable and eco-friendly materials for bioprocess bags, driven by the need to reduce environmental impact and improve the overall sustainability of biomanufacturing processes, which is expected to notably contribute toward the market growth. However, generation of generates a significant amount of plastic waste due to single-use bioprocess bags coupled with rise in concerns about environmental impact and increase in pressure for sustainable disposal methods hamper the market growth. Moreover, potential risk associated with contamination of products due to leachable and extractables from the polymer materials used in bioprocess bags restrain the use of bioprocess bags. On the contrary, continuous advancements in the materials and design of bioprocess bags, such as improved barrier properties and compatibility with a broader range of bioprocessing applications, are expected to offer lucrative opportunities for the market growth during the forecast period. In addition, manufacturers are focusing on improving sterility and maintaining product integrity of bioprocess bags, which will address the critical need for contamination-free production in high-value biologics. Such developments are anticipated to open new avenues for the market growth.

The global bioprocess bags industry is segmented into type, workflow, end user, and region. On the basis of type, the market is bifurcated into 2D bioprocess bags, 3D bioprocess bags, and others. By workflow, it is divided into upstream process, downstream process, and process development. Depending on end user, it is segregated into pharmaceutical & biopharmaceutical companies, CMOs & CROs, and academic & research institute. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By type, the 2D bioprocess bags segment is expected to dominate the market from 2024 to 2033.

On the basis of workflow, the upstream process segment is anticipated to exhibit the highest growth during the forecast period.

Depending on end user, pharmaceutical & biotechnology companies is projected to emerge as the leading segment in the coming years.

Region wise, North America held the largest market share, in terms of revenue, in 2023, and is expected to dominate the market during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global bioprocess bags market include Thermo Fisher Scientific Inc., Sartorius AG, Merck KGaA, Danaher Corporation, Saint-Gobain Performance Plastics., Lonza Group AG, Eppendorf AG, Meissner Filtration Products, Inc., PBS Biotech, Inc., and GE Healthcare. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles

Key Market Segments

By Type

  • 2D bioprocess bags
  • 3D bioprocess bags
  • Others

By Workflow

  • Upstream Process
  • Downstream Process
  • Process Development

By End User

  • Pharmaceutical and Biopharmaceutical Companies
  • CMOs and CROs
  • Academic and Research Institute

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Thermo Fisher Scientific Inc.
    • Sartorius AG
    • Merck KGaA
    • Danaher Corporation
    • Saint-Gobain Performance Plastics.
    • Lonza Group AG
    • Eppendorf AG
    • Meissner Filtration Products, Inc.
    • PBS Biotech, Inc.
    • GE Healthcare

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: BIOPROCESS BAGS MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. 2D Bioprocess Bags
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. 3D Bioprocess Bags
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Others
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: BIOPROCESS BAGS MARKET, BY WORKFLOW

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Workflow
  • 5.2. Upstream Process
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Downstream Process
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Process Development
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: BIOPROCESS BAGS MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Pharmaceutical And Biopharmaceutical Companies
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. CMOs And CROs
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Academic And Research Institute
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: BIOPROCESS BAGS MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Workflow
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Bioprocess Bags Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Workflow
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Bioprocess Bags Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Workflow
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Bioprocess Bags Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Workflow
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Workflow
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Bioprocess Bags Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Workflow
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Bioprocess Bags Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Workflow
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Bioprocess Bags Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Workflow
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Bioprocess Bags Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Workflow
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Bioprocess Bags Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Workflow
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Bioprocess Bags Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Workflow
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Workflow
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Bioprocess Bags Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Workflow
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Bioprocess Bags Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Workflow
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Bioprocess Bags Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Workflow
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Bioprocess Bags Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Workflow
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Bioprocess Bags Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Workflow
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Bioprocess Bags Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Workflow
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Workflow
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Bioprocess Bags Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Workflow
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Bioprocess Bags Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Workflow
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Bioprocess Bags Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Workflow
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Bioprocess Bags Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Workflow
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Thermo Fisher Scientific Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Sartorius AG
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Merck KGaA
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Danaher Corporation
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Saint-Gobain Performance Plastics.
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Lonza Group AG
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Eppendorf AG
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Meissner Filtration Products, Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. PBS Biotech, Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. GE Healthcare
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments